1. Omsk State Medical University of the Ministry of Health of Russia (Omsk, Russian Federation)
2. Regional Clinical Hospital (Omsk, Russian Federation)
3. Nizhnevartovsk District Clinical Hospital (Nizhnevartovsk, Russian Federation)

Keywords:cholecystocholangiolithiasis,minimally invasive surgery,fibrocholangioscopy,postoperative period,quality of life,ursodeoxycholic acid (UDCA)

Abstract:In the study, two groups of patients were compared: 31 patients operated with a single-step minimally invasive surgical method and 28 patients who were operated with a two-stage surgical procedure. To study the long-term results of treatment in patients with cholecystocholangiolithiasis who underwent surgical treatment, a questionnaire survey (questionnaire SF-36) and a survey including clinical (complaints, examination), laboratory tests (blood and urine test, bilirubin level, ALAT, ACAT, AF) and instrumental (ultrasound, fibrogastroduodenoscopy) research methods. The obtained results of the conducted study testify to the undoubted advantage of one-stage minimally invasive surgical treatment of patients with cholecystocholangiolithiasis. Quality of life indicators in patients taking UDCA drugs at the postoperative stage of smoking were better in comparison with patients who did not take UDCA, which may serve as an additional reason for prescribing UDCA drugs after cholecystectomy. The received results of the conducted research testify to an undoubted advantage of one-stage minimally invasive surgical treatment of patients with cholecystocholangiolithiasis.

• References total 39 ⇓ :: .
  1. Lazebnik L. B., Kopaneva M. I., Ezhova T. B. Sravnitel’noe issledovanie kachestva zhizni u bol’nykh zhelchnokamennoi bolezn’yu i postkholetsistektomicheskim sindromom. Materialy 5-go Slavyano-Baltiiskogo nauchnogo foruma. Sankt-Peterburg. Gastro, 2003; 2–3:93.
  2. Lazebnik L. B., Kopaneva, I.M., Ezhova T. B. Need for medical care after surgery on the stomach and gall bladder (Review of references and own observations). Terapevtichesky Arkhiv, 2004, 2: 83–87.
  3. Minushkin O. N. Syndrome after cholecystectomy in the practice of the therapist and the gastroenterologist. Lechaschy Vrach, 2015, 2: 40–47.
  4. Minushkin O. N., Guseva L. V., Burdina E. G. i dr. Bol’nye posle udaleniya zhelchnogo puzyrya. Vsegda li eto postkholetsistektomicheskii sindrom? Medical Advice. 2016;14: 122–8.
  5. Vinokurov M. M., Pavlov I. A., Gogolev N. M. i dr. Khirurgicheskoe lechenie bol’nykh ostrym kal’kuleznym kholetsistitom, oslozhnennym kholedokholitiazom i mekhanicheskoi zheltukhoi. Annaly khirurgicheskoi gepatologii. 2004;2:114–5.
  6. Collins C., Maguire D., Ireland A. A prospective study of common bile duct calculi in patients undergoing laparoscopic cholecystectomy: natural history of choledocholithiasis revisited. Ann. Surg. 2004;1: 28–33.
  7. Vetshev P. S., Chilingaridi K. E., Ippolitov L. I. et al. Life quality of patients after various methods of cholecystectomy. Annaly khirurgicheskoi gepatologii,. 2003; 8 (1): 72–79. – (In Russ.)
  8. Beburishvili A. G., Bykov A. V., Zyubina E. N., Burchuladze N. Sh. Evolyutsiya podkhodov k khirurgicheskomu lecheniyu oslozhnennogo kholetsistita. Khirurgiya. Zhurnal im. N. I. Pirogova. 2005;1: 43–7.
  9. Bystrovskaya E. V., Il’chenko A. A. Otdalennye rezul’taty kholetsistektomii. Eksperimental’naya i klinicheskaya gastroenterologiya. 2008; 5: 23–7.
  10. Aliev Yu. G., Kurbanov F. S., Popovich V. K. et al. Maloinvazivnoe khirurgicheskoe lechenie ostrogo i oslozhnennogo kal’kuleznogo kholetsistita. Moscow Surgical Journal. 2014; 2: 35–8.
  11. Franks, P., Lubetkin, E., Gold, M. R. et al. Mapping the SF-12 to the EuroQol EQ-5D Index in a National US Sample. Medical Decision Making. 2004. 24(3), 247–254. doi: 10.1177/0272989X04265477.
  12. Brazier J., Roberts J. & Deverill M. The Estimation of a Preference-based Measure of Health from the SF-36. Journal of Health Economics. 2004. 21(2), 271–292
  13. Novik A. A. Issledovanie kachestva zhizni v meditsine: ucheb. posobie. M., GEOTAR-MED. 2004. P. 304
  14. Quintana J. M., Cabriada J., Arostegui I. et al. Quality-of-life outcomes with laparoscopic vs open cholecystectomy Surg. Endocs. 2003;17:1129–34.
  15. Cherkasov M. F., Kuzmenko V. L. Possibility of forecasting cholecystectomy long-term results. Modern problems of science and education. 2016;3: 178–87
  16. Savchenko Y. P., Bensman V. M., Karipidi G. K., Gumenyuk S. E., Suzdaltsev I. V. Long-term results of surgical treatment of cholecystitis, depending on the method of cholecystectomy Kuban Scientific Medical Bulletin 2016;5: 98–101
  17. Trukhan D. I. Rational pharmacotherapy in gastroenterology. Spravochnik poliklinicheskogo vracha. 2012; 10: 18–24. (In Russ.)
  18. Trukhan D. I., Filimonov S. N., Tarasova L. V. Klinika, diagnostika i lechenie osnovnykh zabolevanii zhelchnogo puzyrya i zhelchevyvodyashchikh putei. Novokuznetsk: OOO.Poligrafist., 2013. p. 111
  19. Trukhan D. I., Filimonov S. N., Tarasova L. V. Klinika, diagnostika i lechenie osnovnykh zabolevanii zhelchnogo puzyrya i zhelchevyvodyashchikh putei. Novokuznetsk: OOO.Poligrafist., 2013. p.154
  20. Trukhan D. I., Tarasova L. V. Drug safety and rational drug therapy in gastroenterologic practice. Klinicheskiye Perspektivy Gastroenterologii, Gepatologii, 2013, 5: 9–16.
  21. Tarasova L. V., Trukhan D. Idrug safety in gastroenterology. Eksperimental’naya i klinicheskaya gastroenterologiya 2013; 4: 81–7.
  22. Trukhan D. I. Vybor lekarstvennogo preparata s pozitsii ratsional’noi farmakoterapii. Consilium Medicum. 2013; 11: 45–9.
  23. Trukhan D. I. Originaly i generiki: perezagruzka v svete ekonomicheskogo krizisa. Spravochnik poliklinicheskogo vracha. 2012;4: 32–6.
  24. Kazyulin A. N. Place of ursodeoxycholic acid in the therapy of non-alcoholic fatty liver disease at different stages: steatosis, steatohepatitis, fibrosis / cirrhosis. RMJ. 2017. № 17. P. 1248–1257.
  25. Kazyulin A. N., Goncharenko A. Yu., Kalyagin I. E. Application of ursodezoxycolic acid for prevention and treatment of cholelithiasis in the practice of the first contact physicians. RMJ. MEDICAL REVIEW. 2017. № 2. P. 80–87.
  26. E. V. Esaulenko, O. E. Nikitina, N. V. Dunaeva, A. N. Uskov, T. L. Mogilevets. Clinical experience with ursodeoxycholic acid (Urdoxa) in complex therapy of chronic viral hepatitis. Journal Infectology 2011; 3: 42–5. (In Russ.)
  27. Sologub T. V., Osinovets O. Y. Experience of application of Urdox drug in patients of chronic hepatitis in the cirrhosis stage. Terra Medica, 2012, 2: 9–17. (In Russ.)
  28. Baranovskii A. Yu., Raikhel’son K. L., Semenov N. V., Solonitsyn E. G. Principles of cholestatic liver diseases treatment. Lechashchii vrach. 2012; 7: 43–9. (In Russ.)
  29. Zinovieva E. N., Mekhtiev S. N., Mekhtieva O. A. Modern aspects of pathogenetic therapy of non-alcoholic fatty liver disease. Effective Pharmacotherapy. Gastroenterology. 2012;26: 24–9. (In Russ.)
  30. Veselova E. N., Alekseev E. E., Mkrtchyan L. S. Place ursodeoxycholic acid in modern hepatology. Medical bulletin of the South Russia. 2012; 1: 36–9.
  31. Avalueva EB, Tkachenko EI, Skazyevaeva EV et al. Efficiency of ursodeoxycholic acid therapy in non-alcoholic fatty liver disease associated with metabolic syndrome. Experimental and clinical gastroenterology/ Eksp Klin Gastroenterol. 2013; 11: 26–30. (In Russ.)
  32. Zubritsky V. F., Gibadulin N. V., Kostyuchenko M. V. Рrevention of post-operation hepatorenal syndrome. Effective Pharmacotherapy. Gastroenterology. 2013; 1: 42–8. (In Russ.)
  33. L. N. Kostyuchenko. Nutritional support for postcolectomy syndrome: what’s new? Effective Pharmacotherapy. Gastroenterology. 2013; 3 (31): 10–4 (In Russ.)
  34. Trukhan D. I., Viktorova I. A. Gallbladder disease and biliary tract in practice doctor first contact: passive waiting or active surveillance. Medical Advice. 2016; 14:109–15 DOI: http://dx.doi.org/10.21518/2079–701X-2016–14–109–115
  35. Myazin R. G. The role of ursodeoxycholic acid in the treatment of chronic viral hepatitis. Medical Advice. 2017;4: 31–5. DOI: http://dx.doi.org/10.21518/2079–701X-2017–4–31–35
  36. Pimanov S. I., Makarenko Е. V. Idiosyncratic drug-induced liver injury: diagnosis and treatment. Medical Advice. 2017; 5:100–7. (In Russ.)
  37. Tsukanov V. V., Tonkikh Yu. L., Vasyutin A. V. Recommendations for management of patients with functional disorders of the gall bladder and sphincter of Oddi. Medical advice. 2017; 11: 100–3. (In Russ.)
  38. Shul’pekova Yu. O., Shul’pekova N. V., Semenistaya M. Ch. Clinical and pathogenetic substantiation of the use of ursodeoxycholic acid in the treatment of cholelithiasis. Russian Medical Journal. 2017; 10: 745–9. (In Russ.)
  39. Kazyulin A. Place of ursodeoxycholic acid in the therapy of non-alcoholic fatty liver disease at different stages of the disease: steatosis, steatohepatitis, fibrosis / cirrhosis. MEDICAL ALPHABET. 2017; 40: 50–60 (In Russ.)

Full text is published :
ANALIS LONG-TERM RESULTS OF MINIMALLY INVASIVE SURGICAL TREATMENT OF PATIENTS WITH CHOLECYSTOCHOLANGIOLITHIASIS. Experimental and Clinical Gastroenterology Journal. 2018;150(02):74-81
Read & Download full text